About: Moderna
Sanofi announces encouraging results for its booster against Omicron variant
French pharmaceutical company Sanofi announced on Monday (13 June) encouraging results for its new generation vaccine against COVID, developed in collaboration with British company GSK, after two conclusive clinical trials.
Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed
An Omicron-specific booster could be ready by August, the CEO of U.S. biotech firm Moderna told Reuters, but the firm is still gathering clinical data to determine whether that vaccine would offer better protection than a new dose of the existing jab.
Big Pharma preventing vaccine access to low-income countries, says Amnesty report
In low-income countries, the fully vaccinated account for less than 1% of the population compared to the 55% fully vaccinated in rich countries, according to a report published by Amnesty International on Wednesday (22 September), which accuses pharmaceutical companies of obstructing access to vaccines. EURACTIV France reports.
Japan detects no health risks in withdrawn Moderna vaccine doses from Spain
Japan has not registered for the moment any health problems in patients inoculated with the Moderna vaccine related to the contamination detected in a batch of doses from Spain, according to sources from the county’s health ministry quoted on Friday (27 August) by EURACTIV’s partner EFE.
EMA approves second vaccine for children aged 12 to 17 in EU
EMA’s human medicines committee (CHMP) on Friday (23 July) has recommended granting an extension of indication for the COVID-19 vaccine Spikevax, previously COVID-19 Vaccine Moderna, to include use in children aged 12 to 17 years.
Spain expects to have its own COVID-19 vaccine ready this year
Spain expects to launch a COVID-19 vaccine before the end of the year, according to Prime Minister Pedro Sánchez, who described Spanish pharmaceutical firm Hipra's vaccine candidate as one of Europe's most promising to end the pandemic, EURACTIV’s partner EFE reported.